Form 8-K - Current report:
SEC Accession No. 0001396814-25-000055
Filing Date
2025-04-22
Accepted
2025-04-22 08:59:40
Documents
13
Period of Report
2025-04-17
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K pcrx-20250417.htm   iXBRL 8-K 21636
  Complete submission text file 0001396814-25-000055.txt   146396

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20250417.xsd EX-101.SCH 1792
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20250417_lab.xml EX-101.LAB 22771
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20250417_pre.xml EX-101.PRE 13050
16 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20250417_htm.xml XML 2831
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005 650-242-8052
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 25855665
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)